- Home
- DVAX vs BTE Comparison
DVAX vs BTE Comparison
Compare DVAX & BTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- BTE
- Stock Information
- Founded
- DVAX 1996
- BTE 1993
- Country
- DVAX United States
- BTE Canada
- Employees
- DVAX N/A
- BTE N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- BTE Meat/Poultry/Fish
- Sector
- DVAX Health Care
- BTE Consumer Staples
- Exchange
- DVAX Nasdaq
- BTE Nasdaq
- Market Cap
- DVAX 1.3B
- BTE 1.4B
- IPO Year
- DVAX 2004
- BTE N/A
- Fundamental
- Price
- DVAX $11.36
- BTE $2.07
- Analyst Decision
- DVAX Buy
- BTE Hold
- Analyst Count
- DVAX 4
- BTE 1
- Target Price
- DVAX $26.25
- BTE $5.50
- AVG Volume (30 Days)
- DVAX 1.6M
- BTE 33.8M
- Earning Date
- DVAX 08-05-2025
- BTE 07-31-2025
- Dividend Yield
- DVAX N/A
- BTE 3.12%
- EPS Growth
- DVAX N/A
- BTE N/A
- EPS
- DVAX N/A
- BTE 0.28
- Revenue
- DVAX $294,620,000.00
- BTE $2,327,227,884.00
- Revenue This Year
- DVAX $21.18
- BTE $3.43
- Revenue Next Year
- DVAX $16.83
- BTE N/A
- P/E Ratio
- DVAX N/A
- BTE $7.39
- Revenue Growth
- DVAX 24.76
- BTE 10.55
- 52 Week Low
- DVAX $9.22
- BTE $1.36
- 52 Week High
- DVAX $14.63
- BTE $3.76
- Technical
- Relative Strength Index (RSI)
- DVAX 66.09
- BTE 60.18
- Support Level
- DVAX $10.38
- BTE $1.90
- Resistance Level
- DVAX $11.48
- BTE $2.15
- Average True Range (ATR)
- DVAX 0.30
- BTE 0.10
- MACD
- DVAX 0.08
- BTE 0.02
- Stochastic Oscillator
- DVAX 90.40
- BTE 77.81
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
About BTE Baytex Energy Corp
Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.